84-4447-80　［受注停止］MYH9 (Myosin Heavy Chain 9, Non Muscle, DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA, Nonmuscle Myosin Heavy Chain II-A, Cellular Myosin Heavy Chain, Type A) 200ul　369582

特徴

• MYH9 polymorphisms are thought to contribute to glomerulosclerosis and non-diabetic end stage renal disease in African Americans.
• This gene encodes a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain.
• The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape.
• Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.
• The genomic coordinates used for the transcript record were based on alignments.
• Applications: Suitable for use in ELISA, Western Blot, Immunoprecipitation, Immunohistochemistry, Immunocytochemistry.
• Other applications not tested.
• Recommended Dilution:ELISA: 1:100-1:5000Western Blot: 1:50-400Immunohistochemistry (frozen): 1:50-500Immunohistochemistry (paraffin): 1:10-100Immunocytochemistry: 1:50-500Optimal dilutions to be determined by the researcher.
• Storage and Stability:May be stored at 4°C for short-term only.
• Aliquot to avoid repeated freezing and thawing.
• Store at -20°C.
• Aliquots are stable for 12 months.
• For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.